Related Experiment Video
Updated: Sep 3, 2025

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
Conjunctival Lymphoma
Lindsay A McGrath1,2, David A Ryan3, Sunil K Warrier4
1Queensland Ocular Oncology Service, Terrace Eye Centre, Brisbane, QLD, Australia. lindsay.mcg@gmail.com.
Insights
Conjunctival lymphoma, often extranodal marginal zone B-cell lymphoma (EMZL), presents as painless lesions. Advances in molecular diagnostics improve prediction of recurrence and systemic disease for this ocular malignancy.
Area of Science:
- Ophthalmology
- Oncology
- Hematology
Background:
- Conjunctival lymphoma is an ocular malignancy originating from lymphocytes.
- Extranodal marginal zone B-cell lymphoma (EMZL) is the most common subtype, but others like DLBCL, FL, MCL, and T-cell lymphomas also occur.
- Clinical presentation is often non-specific, characterized by painless, salmon-pink conjunctival lesions.
Purpose of the Study:
- To review the classification, clinical features, diagnostic techniques, and management strategies for conjunctival lymphomas.
- To highlight emerging prognostic indicators based on cytogenetic and molecular features.
Main Methods:
- Review of existing literature on conjunctival lymphoma.
- Analysis of clinical manifestations and diagnostic approaches.
- Evaluation of current and emerging treatment modalities.
- Assessment of advancements in molecular diagnostics for prognostication.
Main Results:
- Conjunctival lymphoma encompasses various subtypes, with EMZL being predominant.
- Standard treatments include local immunomodulation (Interferon-α2b, Rituximab) and radiation.
- Next-generation sequencing offers improved prediction of recurrence and systemic spread.
- Cytogenetic and molecular features are crucial for prognostication.
Conclusions:
- Conjunctival lymphoma management is evolving with improved diagnostic and prognostic tools.
- Personalized treatment strategies can be informed by molecular profiling.
- Early detection and accurate prognostication are key to managing this ocular malignancy.
Abstract:
Lymphoma of the conjunctiva is an ocular malignancy derived from clonal proliferation of lymphocytes. The majority of conjunctival lymphoma is extranodal marginal zone B-Cell lymphoma (EMZL), however diffuse large B-cell (DLBCL), follicular (FL), mantle cell (MCL) and T- cell subtypes are also seen. Clinical manifestations are non-specific, but include unilateral or bilateral painless salmon-pink conjunctival lesions. Approaches to treatment have centered around local immunomodulation, often with Interferon-α2b or Rituximab (anti-CD20 monoclonal antibody) with or without radiation. Although conjunctival lymphoma is generally considered an indolent disease, recent advances in next-generation sequencing have improved clinicians' ability to predict future recurrence or systemic disease through assessment of cytogenic and molecular features. In this paper, we review the classification, clinical features, diagnostic techniques, and emerging strategies for management and prognostication of conjunctival lymphomas.
More Related Videos
06:20Author Spotlight: Advancing VRL Diagnosis Using Cell-Free DNA Extraction from Vitreous Humor
Published on: January 12, 2024
08:04A Rabbit Model of Aqueous-Deficient Dry Eye Disease Induced by Concanavalin A Injection into the Lacrimal Glands: Application to Drug Efficacy Studies
Published on: January 24, 2020
Related Concept Videos
Secondary Lymphoid Organs
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Lymphoid Cells and Tissues
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Angle Closure Glaucoma: Treatment
Lymphatic Vessels and Lymph Transport
This one-way system allows fluids, solutes, and even pathogens to enter but prevents their return to the intercellular...
Glaucoma: Overview